MEA High Content Screening Market - Industry Trends and Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION 30

• 1.1 OBJECTIVES OF THE STUDY 30
• 1.2 MARKET DEFINITION 30
• 1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET 30
• 1.4 LIMITATIONS 32
• 1.5 MARKETS COVERED 32

2 MARKET SEGMENTATION 36

• 2.1 MARKETS COVERED 36
• 2.2 GEOGRAPHICAL SCOPE 37
• 2.3 YEARS CONSIDERED FOR THE STUDY 38
• 2.4 CURRENCY AND PRICING 38
• 2.5 DBMR TRIPOD DATA VALIDATION MODEL 39
• 2.6 MULTIVARIATE MODELLING 42
• 2.7 PRODUCT TYPE LIFELINE CURVE 42
• 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 43
• 2.9 DBMR MARKET POSITION GRID 44
• 2.10 MARKET APPLICATION COVERAGE GRID 45
• 2.11 VENDOR SHARE ANALYSIS 46
• 2.12 SECONDARY SOURCES 47
• 2.13 ASSUMPTIONS 47

3 EXECUTIVE SUMMARY 48

4 PREMIUM INSIGHTS 50

• 4.1 PESTEL ANALYSIS 51
• 4.2 PORTER'S FIVE FORCES MODEL 52

5 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: REGULATIONS 53

6 MARKET OVERVIEW, MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET 55

• 6.1 DRIVERS 57
  • 6.1.1 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH CONTENT SCREENING 57
  • 6.1.2 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS 57
  • 6.1.3 INCREASING RESEARCH ACTIVITIES ASSOCIATED WITH THE USAGE OF HIGH CONTENT SCREENING 58
  • 6.1.4 INCREASING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 59
• 6.2 RESTRAINTS 59
  • 6.2.1 HIGH COST ASSOCIATED WITH INITIAL SETUP AND MAINTENANCE 59
  • 6.2.2 COMPLEXITY ASSOCIATED WITH CELLULAR AND MOLECULAR SAMPLES 60
• 6.3 OPPORTUNITIES 61
  • 6.3.1 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS (CROS) PROVIDING HCS SERVICES 61
  • 6.3.2 RISING INTEGRATION WITH ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DISCOVERY AND DEVELOPMENT 61
  • 6.3.3 INCREASING GOVERNMENT INITIATIVE AND FUNDING IN R&D 62
• 6.4 CHALLENGES 62
  • 6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE HCS 62
  • 6.4.2 DATA SECURITY AND DATA MANAGEMENT PROBLEMS IN HCS 63

7 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE 64

• 7.1 OVERVIEW 65
• 7.2 INSTRUMENTS 68
  • 7.2.1 CELL IMAGING AND ANALYSIS SYSTEM 69
    • 7.2.1.1 FIXED 69
    • 7.2.1.2 MOBILE 69
  • 7.2.2 HIGH-CONTENT AND SCREENING SYSTEM 69
    • 7.2.2.1 FIXED 70
    • 7.2.2.2 MOBILE 70
  • 7.2.3 FLOW CYTOMETRY 70
  • 7.2.4 INVITROGEN HCA ONSTAGE INCUBATOR 70
  • 7.2.5 MICROPLATE MOVER 70
  • 7.2.6 OTHERS 70
• 7.3 SOFTWARE 70
• 7.4 CONSUMABLES 71
  • 7.4.1 REAGENTS & ASSAY KITS 72
  • 7.4.2 MICROPLATES 72
  • 7.4.3 OTHERS 72
• 7.5 ACCESSORIES 72
• 7.6 SERVICES 73

8 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY APPLICATION 75

• 8.1 OVERVIEW 76
• 8.2 PRIMARY AND SECONDARY SCREENING 79
  • 8.2.1 INSTRUMENTS 80
  • 8.2.2 CONSUMABLES 80
  • 8.2.3 ACCESSORIES 80
  • 8.2.4 SERVICES 80
• 8.3 TARGET IDENTIFICATION AND VALIDATION 80
  • 8.3.1 INSTRUMENTS 81
  • 8.3.2 CONSUMABLES 81
  • 8.3.3 ACCESSORIES 81
  • 8.3.4 SERVICES 82
• 8.4 TOXICITY STUDIES 82
  • 8.4.1 INSTRUMENTS 83
  • 8.4.2 CONSUMABLES 83
  • 8.4.3 ACCESSORIES 83
  • 8.4.4 SERVICES 83
• 8.5 COMPOUND PROFILING 83
  • 8.5.1 INSTRUMENTS 84
  • 8.5.2 CONSUMABLES 84
  • 8.5.3 ACCESSORIES 84
  • 8.5.4 SERVICES 85
• 8.6 OTHER APPLICATIONS 85

9 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY 86

• 9.1 OVERVIEW 87
• 9.2 MICROSCOPY 90
• 9.3 FLOW CYTOMETRY 90
• 9.4 IMMUNOHISTOCHEMISTRY 91
• 9.5 MASS SPECTROMETRY 92
• 9.6 ELISA 93
• 9.7 WESTERN BLOTTING 94
• 9.8 OTHERS 94
  • 9.8.1 3D CELL CULTURE MODEL 95
    • 9.8.1.1 STEROIDS 96
    • 9.8.1.2 ORGANOIDS 96
    • 9.8.1.3 TISSUE ON A CHIP 96
  • 9.8.2 EXTRACELLULAR MATRIX BASED SCAFFOLD 96
  • 9.8.3 SYNTHETIC HYDROGEL AND SCAFFOLD 96

10 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY END USER 97

• 10.1 OVERVIEW 98
• 10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 101
  • 10.2.1 INSTRUMENTS 101
  • 10.2.2 CONSUMABLES 102
  • 10.2.3 ACCESSORIES 102
  • 10.2.4 SERVICES 102
• 10.3 CONTRACT RESEARCH ORGANIZATIONS 102
  • 10.3.1 INSTRUMENTS 103
  • 10.3.2 CONSUMABLES 103
  • 10.3.3 ACCESSORIES 103
  • 10.3.4 SERVICES 103
• 10.4 LABORATORIES 104
  • 10.4.1 INSTRUMENTS 105
  • 10.4.2 CONSUMABLES 105
  • 10.4.3 ACCESSORIES 105
  • 10.4.4 SERVICES 105
• 10.5 ACADEMIC AND GOVERNMENT INSTITUTES 105
  • 10.5.1 INSTRUMENTS 106
  • 10.5.2 CONSUMABLES 106
  • 10.5.3 ACCESSORIES 106
  • 10.5.4 SERVICES 106
• 10.6 OTHERS 107

11 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL 108

• 11.1 OVERVIEW 109
• 11.2 DIRECT TENDERS 112
• 11.3 RETAIL SALES 112

12 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY REGION 114

• 12.1 MIDDLE EAST AND AFRICA 115
  • 12.1.1 SOUTH AFRICA 126
  • 12.1.2 SAUDI ARABIA 133
  • 12.1.3 BAHRAIN 140
  • 12.1.4 U.A.E 147
  • 12.1.5 KUWAIT 154
  • 12.1.6 OMAN 161
  • 12.1.7 QATAR 168
  • 12.1.8 EGYPT 175
  • 12.1.9 ISRAEL 182
  • 12.1.10 REST OF MIDDLE EAST AND AFRICA 189

13 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, COMPANY LANDSCAPE 190

• 13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 190

14 MIDDLE EAST & AFRICA CONTENT SCREENING MARKET, COMPANY PROFILES 191

• 14.1 THERMO FISHER SCIENTIFIC INC. (2022) 191
  • 14.1.1 COMPANY SNAPSHOT 191
  • 14.1.2 REVENUE ANALYSIS 191
  • 14.1.3 COMPANY SHARE ANALYSIS 192
  • 14.1.4 PRODUCT PORTFOLIO 192
  • 14.1.5 RECENT DEVELOPMENT 192
• 14.2 BD 193
  • 14.2.1 COMPANY SNAPSHOT 193
  • 14.2.2 REVENUE ANALYSIS 193
  • 14.2.3 COMPANY SHARE ANALYSIS 194
  • 14.2.4 PRODUCT PORTFOLIO 194
  • 14.2.5 RECENT DEVELOPMENTS 194
• 14.3 PERKINELMER INC. (2022) 195
  • 14.3.1 COMPANY SNAPSHOT 195
  • 14.3.2 REVENUE ANALYSIS 195
  • 14.3.3 COMPANY SHARE ANALYSIS 196
  • 14.3.4 PRODUCT PORTFOLIO 196
  • 14.3.5 RECENT DEVELOPMENTS 197
• 14.4 YOKOGAWA ELECTRIC CORPORATION (2022) 198
  • 14.4.1 COMPANY SNAPSHOT 198
  • 14.4.2 REVENUE ANALYSIS 198
  • 14.4.3 COMPANY SHARE ANALYSIS 199
  • 14.4.4 PRODUCT PORTFOLIO 199
  • 14.4.5 RECENT DEVELOPMENT 199
• 14.5 MOLECULAR DEVICES, LLC. (A SUBSIDIARY OF DANAHER CORPORATION) 200
  • 14.5.1 COMPANY SNAPSHOT 200
  • 14.5.2 REVENUE ANALYSIS 200
  • 14.5.3 COMPANY SHARE ANALYSIS 201
  • 14.5.4 PRODUCT PORTFOLIO 201
  • 14.5.5 RECENT DEVELOPMENT 202
• 14.6 AGILENT TECHNOLOGIES, INC. (2022) 203
  • 14.6.1 COMPANY SNAPSHOT 203
  • 14.6.2 REVENUE ANALYSIS 203
  • 14.6.3 PRODUCT PORTFOLIO 204
  • 14.6.4 RECENT DEVELOPMENT 204
• 14.7 ALIGNED GENETICS, INC. (2022) 205
  • 14.7.1 COMPANY SNAPSHOT 205
  • 14.7.2 REVENUE ANALYSIS 205
  • 14.7.3 PRODUCT PORTFOLIO 206
  • 14.7.4 RECENT DEVELOPMENT 206
• 14.8 ARACELI BIOSCIENCES 207
  • 14.8.1 COMPANY SNAPSHOT 207
  • 14.8.2 PRODUCT PORTFOLIO 207
  • 14.8.3 RECENT DEVELOPMENT 207
• 14.9 AXXAM S.P.A 208
  • 14.9.1 COMPANY SNAPSHOT 208
  • 14.9.2 PRODUCT PORTFOLIO 208
  • 14.9.3 RECENT DEVELOPMENT 208
• 14.10 BIO-RAD LABORATORIES, INC. (2022) 209
  • 14.10.1 COMPANY SNAPSHOT 209
  • 14.10.2 REVENUE ANALYSIS 209
  • 14.10.3 PRODUCT PORTFOLIO 210
  • 14.10.4 RECENT DEVELOPMENTS 210
• 14.11 CARL ZEISS AG 211
  • 14.11.1 COMPANY SNAPSHOT 211
  • 14.11.2 REVENUE ANALYSIS 211
  • 14.11.3 PRODUCT PORTFOLIO 212
  • 14.11.4 RECENT DEVELOPMENT 212
• 14.12 CORNING INCORPORATED 213
  • 14.12.1 COMPANY SNAPSHOT 213
  • 14.12.2 REVENUE ANALYSIS 213
  • 14.12.3 PRODUCT PORTFOLIO 214
  • 14.12.4 RECENT DEVELOPMENT 214
• 14.13 DE NOVO SOFTWARE 215
  • 14.13.1 COMPANY SNAPSHOT 215
  • 14.13.2 PRODUCT PORTFOLIO 215
  • 14.13.3 RECENT DEVELOPMENTS 215
• 14.14 EVIDENT 216
  • 14.14.1 COMPANY SNAPSHOT 216
  • 14.14.2 PRODUCT PORTFOLIO 216
  • 14.14.3 RECENT DEVELOPMENT 216
• 14.15 GENEDATA AG 217
  • 14.15.1 COMPANY SNAPSHOT 217
  • 14.15.2 PRODUCT PORTFOLIO 217
  • 14.15.3 RECENT DEVELOPMENT 217
• 14.16 MERCK KGAA 218
  • 14.16.1 COMPANY SNAPSHOT 218
  • 14.16.2 REVENUE ANALYSIS 218
  • 14.16.3 PRODUCT PORTFOLIO 219
  • 14.16.4 RECENT DEVELOPMENTS 219
• 14.17 MILTENYI BIOTEC 220
  • 14.17.1 COMPANY SNAPSHOT 220
  • 14.17.2 PRODUCT PORTFOLIO 220
  • 14.17.3 RECENT DEVELOPMENT 221
• 14.18 SARTORIUS AG 222
  • 14.18.1 COMPANY SNAPSHOT 222
  • 14.18.2 REVENUE ANALYSIS 222
  • 14.18.3 PRODUCT PORTFOLIO 223
  • 14.18.4 RECENT DEVELOPMENTS 223
• 14.19 SYSMEX CORPORATION 224
  • 14.19.1 COMPANY SNAPSHOT 224
  • 14.19.2 REVENUE ANALYSIS 224
  • 14.19.3 PRODUCT PORTFOLIO 225
  • 14.19.4 RECENT DEVELOPMENT 225
• 14.20 ZIFO RND SOLUTIONS 226
  • 14.20.1 COMPANY SNAPSHOT 226
  • 14.20.2 PRODUCT PORTFOLIO 226
  • 14.20.3 RECENT DEVELOPMENTS 226

15 QUESTIONNAIRE 227

16 RELATED REPORTS 231

LIST OF TABLES

• TABLE 1 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 61
• TABLE 2 MIDDLE EAST & AFRICA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 62
• TABLE 3 MIDDLE EAST & AFRICA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 63
• TABLE 4 MIDDLE EAST & AFRICA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 63
• TABLE 5 MIDDLE EAST & AFRICA HIGH-CONTENT AND SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 64
• TABLE 6 MIDDLE EAST & AFRICA SOFTWARES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 65
• TABLE 7 MIDDLE EAST & AFRICA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 66
• TABLE 8 MIDDLE EAST & AFRICA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 66
• TABLE 9 MIDDLE EAST & AFRICA ACCESSORIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
• TABLE 10 MIDDLE EAST & AFRICA SERVICES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
• TABLE 11 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 72
• TABLE 12 MIDDLE EAST & AFRICA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
• TABLE 13 MIDDLE EAST & AFRICA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 74
• TABLE 14 MIDDLE EAST & AFRICA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
• TABLE 15 MIDDLE EAST & AFRICA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 75
• TABLE 16 MIDDLE EAST & AFRICA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
• TABLE 17 MIDDLE EAST & AFRICA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 77
• TABLE 18 MIDDLE EAST & AFRICA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 78
• TABLE 19 MIDDLE EAST & AFRICA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 78
• TABLE 20 MIDDLE EAST & AFRICA OTHER APPLICATION IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
• TABLE 21 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 83
• TABLE 22 MIDDLE EAST & AFRICA MICROSCOPY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 84
• TABLE 23 MIDDLE EAST & AFRICA FLOW CYTOMETRY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 85
• TABLE 24 MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
• TABLE 25 MIDDLE EAST & AFRICA MASS SPECTROSCOPY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
• TABLE 26 MIDDLE EAST & AFRICA ELISA IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
• TABLE 27 MIDDLE EAST & AFRICA WESTERN BLOTTING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 88
• TABLE 28 MIDDLE EAST & AFRICA OTHERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 89
• TABLE 29 MIDDLE EAST & AFRICA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 89
• TABLE 30 MIDDLE EAST & AFRICA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 90
• TABLE 31 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 94
• TABLE 32 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
• TABLE 33 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 95
• TABLE 34 MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
• TABLE 35 MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 97
• TABLE 36 MIDDLE EAST & AFRICA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
• TABLE 37 MIDDLE EAST & AFRICA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 98
• TABLE 38 MIDDLE EAST & AFRICA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
• TABLE 39 MIDDLE EAST & AFRICA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 100
• TABLE 40 MIDDLE EAST & AFRICA OTHERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 101
• TABLE 41 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 105
• TABLE 42 MIDDLE EAST & AFRICA DIRECT TENDERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 106
• TABLE 43 MIDDLE EAST & AFRICA RETAIL SALES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 107
• TABLE 44 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 113
• TABLE 45 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
• TABLE 46 MIDDLE EAST AND AFRICA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
• TABLE 47 MIDDLE EAST AND AFRICA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
• TABLE 48 MIDDLE EAST AND AFRICA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
• TABLE 49 MIDDLE EAST AND AFRICA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 115
• TABLE 50 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 115
• TABLE 51 MIDDLE EAST AND AFRICA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 115
• TABLE 52 MIDDLE EAST AND AFRICA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
• TABLE 53 MIDDLE EAST AND AFRICA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
• TABLE 54 MIDDLE EAST AND AFRICA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
• TABLE 55 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 117
• TABLE 56 MIDDLE EAST AND AFRICA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 117
• TABLE 57 MIDDLE EAST AND AFRICA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 117
• TABLE 58 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
• TABLE 59 MIDDLE EAST AND AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
• TABLE 60 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
• TABLE 61 MIDDLE EAST AND AFRICA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
• TABLE 62 MIDDLE EAST AND AFRICA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
• TABLE 63 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 119
• TABLE 64 SOUTH AFRICA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
• TABLE 65 SOUTH AFRICA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
• TABLE 66 SOUTH AFRICA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
• TABLE 67 SOUTH AFRICA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
• TABLE 68 SOUTH AFRICA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
• TABLE 69 SOUTH AFRICA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 121
• TABLE 70 SOUTH AFRICA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
• TABLE 71 SOUTH AFRICA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
• TABLE 72 SOUTH AFRICA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
• TABLE 73 SOUTH AFRICA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
• TABLE 74 SOUTH AFRICA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 123
• TABLE 75 SOUTH AFRICA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 123
• TABLE 76 SOUTH AFRICA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 124
• TABLE 77 SOUTH AFRICA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 124
• TABLE 78 SOUTH AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
• TABLE 79 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
• TABLE 80 SOUTH AFRICA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
• TABLE 81 SOUTH AFRICA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
• TABLE 82 SOUTH AFRICA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 126
• TABLE 83 SAUDI ARABIA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
• TABLE 84 SAUDI ARABIA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
• TABLE 85 SAUDI ARABIA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
• TABLE 86 SAUDI ARABIA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
• TABLE 87 SAUDI ARABIA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
• TABLE 88 SAUDI ARABIA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 129
• TABLE 89 SAUDI ARABIA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 129
• TABLE 90 SAUDI ARABIA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 129
• TABLE 91 SAUDI ARABIA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
• TABLE 92 SAUDI ARABIA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
• TABLE 93 SAUDI ARABIA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 131
• TABLE 94 SAUDI ARABIA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 131
• TABLE 95 SAUDI ARABIA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 131
• TABLE 96 SAUDI ARABIA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 132
• TABLE 97 SAUDI ARABIA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
• TABLE 98 SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
• TABLE 99 SAUDI ARABIA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
• TABLE 100 SAUDI ARABIA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
• TABLE 101 SAUDI ARABIA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 133
• TABLE 102 BAHRAIN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
• TABLE 103 BAHRAIN INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
• TABLE 104 BAHRAIN CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
• TABLE 105 BAHRAIN HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
• TABLE 106 BAHRAIN CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
• TABLE 107 BAHRAIN HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 136
• TABLE 108 BAHRAIN PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 136
• TABLE 109 BAHRAIN TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 136
• TABLE 110 BAHRAIN TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
• TABLE 111 BAHRAIN COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
• TABLE 112 BAHRAIN OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 137
• TABLE 113 BAHRAIN 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 138
• TABLE 114 BAHRAIN HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 138
• TABLE 115 BAHRAIN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
• TABLE 116 BAHRAIN CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
• TABLE 117 BAHRAIN LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
• TABLE 118 BAHRAIN ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
• TABLE 119 BAHRAIN HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 140
• TABLE 120 U.A.E HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
• TABLE 121 U.A.E INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
• TABLE 122 U.A.E CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
• TABLE 123 U.A.E HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 142
• TABLE 124 U.A.E CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 142
• TABLE 125 U.A.E HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 142
• TABLE 126 U.A.E PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 143
• TABLE 127 U.A.E TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 143
• TABLE 128 U.A.E TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 143
• TABLE 129 U.A.E COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
• TABLE 130 U.A.E HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 144
• TABLE 131 U.A.E OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 144
• TABLE 132 U.A.E 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 145
• TABLE 133 U.A.E HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 145
• TABLE 134 U.A.E PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
• TABLE 135 U.A.E CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
• TABLE 136 U.A.E LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
• TABLE 137 U.A.E ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
• TABLE 138 U.A.E HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 147
• TABLE 139 KUWAIT HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
• TABLE 140 KUWAIT INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
• TABLE 141 KUWAIT CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 149
• TABLE 142 KUWAIT HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 149
• TABLE 143 KUWAIT CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 149

• TABLE 144 KUWAIT HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 150
• TABLE 145 KUWAIT PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 150
• TABLE 146 KUWAIT TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 150
• TABLE 147 KUWAIT TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
• TABLE 148 KUWAIT COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
• TABLE 149 KUWAIT HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 152
• TABLE 150 KUWAIT OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 152
• TABLE 151 KUWAIT 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 152
• TABLE 152 KUWAIT HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 153
• TABLE 153 KUWAIT PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
• TABLE 154 KUWAIT CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
• TABLE 155 KUWAIT LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
• TABLE 156 KUWAIT ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
• TABLE 157 KUWAIT HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 154
• TABLE 158 OMAN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
• TABLE 159 OMAN INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
• TABLE 160 OMAN CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
• TABLE 161 OMAN HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
• TABLE 162 OMAN CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
• TABLE 163 OMAN HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 157
• TABLE 164 OMAN PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
• TABLE 165 OMAN TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
• TABLE 166 OMAN TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
• TABLE 167 OMAN COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
• TABLE 168 OMAN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 158
• TABLE 169 OMAN OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 159
• TABLE 170 OMAN 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 159
• TABLE 171 OMAN HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 159
• TABLE 172 OMAN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
• TABLE 173 OMAN CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
• TABLE 174 OMAN LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
• TABLE 175 OMAN ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
• TABLE 176 OMAN HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 161
• TABLE 177 QATAR HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
• TABLE 178 QATAR INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
• TABLE 179 QATAR CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
• TABLE 180 QATAR HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
• TABLE 181 QATAR CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
• TABLE 182 QATAR HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 164
• TABLE 183 QATAR PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 164
• TABLE 184 QATAR TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 164
• TABLE 185 QATAR TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
• TABLE 186 QATAR COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
• TABLE 187 QATAR HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 165
• TABLE 188 QATAR OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 166
• TABLE 189 QATAR 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 166
• TABLE 190 QATAR HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 166
• TABLE 191 QATAR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
• TABLE 192 QATAR CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
• TABLE 193 QATAR LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
• TABLE 194 QATAR ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
• TABLE 195 QATAR HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 168
• TABLE 196 EGYPT HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
• TABLE 197 EGYPT INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
• TABLE 198 EGYPT CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
• TABLE 199 EGYPT HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
• TABLE 200 EGYPT CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
• TABLE 201 EGYPT HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 171
• TABLE 202 EGYPT PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
• TABLE 203 EGYPT TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
• TABLE 204 EGYPT TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
• TABLE 205 EGYPT COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
• TABLE 206 EGYPT HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
• TABLE 207 EGYPT OTHER IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
• TABLE 208 EGYPT 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 173
• TABLE 209 EGYPT HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 173
• TABLE 210 EGYPT PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
• TABLE 211 EGYPT CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
• TABLE 212 EGYPT LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
• TABLE 213 EGYPT ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
• TABLE 214 EGYPT HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 175
• TABLE 215 ISRAEL HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
• TABLE 216 ISRAEL INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
• TABLE 217 ISRAEL CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
• TABLE 218 ISRAEL HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
• TABLE 219 ISRAEL CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
• TABLE 220 ISRAEL HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 178
• TABLE 221 ISRAEL PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 178
• TABLE 222 ISRAEL TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 178
• TABLE 223 ISRAEL TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
• TABLE 224 ISRAEL COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
• TABLE 225 ISRAEL HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 179
• TABLE 226 ISRAEL OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 180
• TABLE 227 ISRAEL 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 180
• TABLE 228 ISRAEL HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 180
• TABLE 229 ISRAEL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
• TABLE 230 ISRAEL CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
• TABLE 231 ISRAEL LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
• TABLE 232 ISRAEL ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
• TABLE 233 ISRAEL HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 182
• TABLE 234 REST OF MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 183

LIST OF FIGURES

• FIGURE 1 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: SEGMENTATION 30
• FIGURE 2 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: DATA TRIANGULATION 33
• FIGURE 3 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: DROC ANALYSIS 34
• FIGURE 4 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 35
• FIGURE 5 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: COMPANY RESEARCH ANALYSIS 35
• FIGURE 6 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: INTERVIEW DEMOGRAPHICS 37
• FIGURE 7 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: DBMR MARKET POSITION GRID 38
• FIGURE 8 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: MARKET APPLICATION COVERAGE GRID 39
• FIGURE 9 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: VENDOR SHARE ANALYSIS 40
• FIGURE 10 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: SEGMENTATION 43
• FIGURE 11 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH-CONTENT SCREENING IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET IN THE FORECAST PERIOD 44
• FIGURE 12 THE PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET IN 2023 AND 2030 44
• FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET 50
• FIGURE 14 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, 2022 59
• FIGURE 15 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, 2023-2030 (USD THOUSAND) 60
• FIGURE 16 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 60
• FIGURE 17 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, LIFELINE CURVE 61
• FIGURE 18 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY APPLICATION, 2022 70
• FIGURE 19 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 71
• FIGURE 20 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY APPLICATION, CAGR (2023-2030) 71
• FIGURE 21 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY APPLICATION, LIFELINE CURVE 72
• FIGURE 22 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, 2022 81
• FIGURE 23 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, 2023-2030 (USD THOUSAND) 82
• FIGURE 24 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, CAGR (2023-2030) 82
• FIGURE 25 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, LIFELINE CURVE 83
• FIGURE 26 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY END USER, 2022 92
• FIGURE 27 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY END USER, 2023-2030 (USD THOUSAND) 93
• FIGURE 28 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY END USER, CAGR (2023-2030) 93
• FIGURE 29 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY END USER, LIFELINE CURVE 94
• FIGURE 30 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2022 103
• FIGURE 31 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 104
• FIGURE 32 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 104
• FIGURE 33 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 105
• FIGURE 34 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET: SNAPSHOT (2022) 110
• FIGURE 35 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022) 111
• FIGURE 36 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2023 & 2030) 111
• FIGURE 37 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022 & 2030) 112
• FIGURE 38 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE (2023-2030) 112
• FIGURE 39 MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET: COMPANY SHARE 2022 (%) 184